These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33613435)

  • 1. The Role of Frontal Assessment Battery and Frontal Lobe Single-Photon Emission Computed Tomography in the Differential Diagnosis of Progressive Supranuclear Palsy Variants and Corticobasal Syndrome-A Pilot Study.
    Alster P; Migda B; Madetko N; Duszyńska-Wąs K; Drzewińska A; Charzyńska I; Starczyński M; Szepelska A; Królicki L; Friedman A
    Front Neurol; 2021; 12():630153. PubMed ID: 33613435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Significance of Asymmetry in the Assessment of Brain Perfusion in Atypical Tauopathic Parkinsonian Syndromes.
    Alster P; Madetko N; Migda B; Nieciecki M; Kutyłowski M; Królicki L; Friedman A
    Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Assessment of Subregions in the Frontal Lobe May Be Feasible in the Differential Diagnosis of Progressive Supranuclear Palsy-Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA).
    Alster P; Madetko-Alster N; Migda B; Nieciecki M; Koziorowski D; Królicki L
    Diagnostics (Basel); 2022 Oct; 12(10):. PubMed ID: 36292111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Strengths and Obstacles in the Differential Diagnosis of Progressive Supranuclear Palsy-Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA) Using Magnetic Resonance Imaging (MRI) and Perfusion Single Photon Emission Computed Tomography (SPECT).
    Alster P; Nieciecki M; Migda B; Kutyłowski M; Madetko N; Duszyńska-Wąs K; Charzyńska I; Koziorowski D; Królicki L; Friedman A
    Diagnostics (Basel); 2022 Feb; 12(2):. PubMed ID: 35204476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of Tau Protein, Metabolism and Perfusion-Application and Efficacy of Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) Imaging in the Examination of Progressive Supranuclear Palsy (PSP) and Corticobasal Syndrome (CBS).
    Alster P; Madetko NK; Koziorowski DM; Królicki L; Budrewicz S; Friedman A
    Front Neurol; 2019; 10():101. PubMed ID: 30837933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is brain perfusion a differentiating feature in the comparison of Progressive Supranuclear Palsy Syndrome (PSPS) and Corticobasal Syndrome (CBS)?
    Alster P; Nieciecki M; Koziorowski D; Cacko A; Charzyńska I; Królicki L; Friedman A
    J Clin Neurosci; 2020 Jul; 77():123-127. PubMed ID: 32389545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants.
    Whitwell JL; Tosakulwong N; Botha H; Ali F; Clark HM; Duffy JR; Utianski RL; Stevens CA; Weigand SD; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Ahlskog JE; Dickson DW; Josephs KA
    Neuroimage Clin; 2020; 25():102152. PubMed ID: 31935638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
    Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
    Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progressive supranuclear palsy-Richardson syndrome with visual attention disturbance (Holmes and Horrax) and ataxie optique (Garcin): a case report].
    Morishima R; Bandoh M; Sunami Y; Isozaki E
    Rinsho Shinkeigaku; 2019 Nov; 59(11):730-735. PubMed ID: 31656263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncovering clinical and radiological asymmetry in progressive supranuclear palsy-Richardson's syndrome.
    Picillo M; Tepedino MF; Abate F; Ponticorvo S; Erro R; Cuoco S; Oksuz N; Di Salle G; Di Salle F; Esposito F; Pellecchia MT; Manara R; Barone P
    Neurol Sci; 2022 Jun; 43(6):3677-3682. PubMed ID: 35106692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal Progression Patterns of Brain Atrophy in Corticobasal Syndrome and Progressive Supranuclear Palsy Revealed by Subtype and Stage Inference (SuStaIn).
    Saito Y; Kamagata K; Wijeratne PA; Andica C; Uchida W; Takabayashi K; Fujita S; Akashi T; Wada A; Shimoji K; Hori M; Masutani Y; Alexander DC; Aoki S
    Front Neurol; 2022; 13():814768. PubMed ID: 35280291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of two Progressive Supranuclear Palsy phenotypes with comparable initial disability.
    Shoeibi A; Litvan I; Tolosa E; Ser TD; Lee E;
    Parkinsonism Relat Disord; 2019 Sep; 66():87-93. PubMed ID: 31307919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes-Infrequent Manifestations of the Most Common Form of Atypical Parkinsonism.
    Krzosek P; Madetko N; Migda A; Migda B; Jaguś D; Alster P
    Front Aging Neurosci; 2022; 14():804385. PubMed ID: 35221993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
    Litvan I; Mangone CA; McKee A; Verny M; Parsa A; Jellinger K; D'Olhaberriague L; Chaudhuri KR; Pearce RK
    J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):615-20. PubMed ID: 8648326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers.
    Vasilevskaya A; Taghdiri F; Multani N; Anor C; Misquitta K; Houle S; Burke C; Tang-Wai D; Lang AE; Fox S; Slow E; Rusjan P; Tartaglia MC
    Front Neurol; 2020; 11():574. PubMed ID: 32754109
    [No Abstract]   [Full Text] [Related]  

  • 16. Utility of Frontal Assessment Battery in detection of neuropsychological dysfunction in Richardson variant of progressive supranuclear palsy.
    Sitek EJ; Konkel A; Dąbrowska M; Sławek J
    Neurol Neurochir Pol; 2015; 49(1):36-40. PubMed ID: 25666771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
    Liscic RM; Srulijes K; Gröger A; Maetzler W; Berg D
    Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The frontal assessment battery is not useful to discriminate progressive supranuclear palsy from frontotemporal dementias.
    Stamelou M; Diehl-Schmid J; Hapfelmeier A; Kontaxopoulou D; Stefanis L; Oertel WH; Bhatia KP; Papageorgiou SG; Höglinger GU
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1264-8. PubMed ID: 26324212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis].
    Morimatsu M; Negoro K; Mori H
    Rinsho Shinkeigaku; 2004 Nov; 44(11):982-5. PubMed ID: 15651349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caregiver strain in progressive supranuclear palsy and corticobasal syndromes.
    Kellermair L; Fuchs A; Eggers C; Schwingenschuh P; Kögl M; Fellner F; Forstner T; Mangesius S; Guger M; Ransmayr G
    J Neural Transm (Vienna); 2021 Oct; 128(10):1611-1621. PubMed ID: 34296340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.